Vivos OTC Stock Management Evaluation
| RDGL Stock | USD 0.08 0 4.22% |
Vivos employs about 1 people. The company is managed by 6 executives with a total tenure of roughly 7 years, averaging almost 1.0 years of service per executive, having 0.17 employees per reported executive. Inspection of Vivos' management performance can provide insight into the company performance.
| Michael Korenko CEO President CEO, Director |
Vivos |
Vivos Management Team Effectiveness
The company has return on total asset (ROA) of (0.6206) % which means that it has lost $0.6206 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.174) %, meaning that it created substantial loss on money invested by shareholders. Vivos' management efficiency ratios could be used to measure how well Vivos manages its routine affairs as well as how well it operates its assets and liabilities.Vivos Workforce Comparison
Vivos Inc is rated second in number of employees category among its peers. The total workforce of Medical Devices industry is at this time estimated at about 495,683. Vivos adds roughly 1.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
Vivos Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Vivos Inc Price Series Summation is a cross summation of Vivos price series and its benchmark/peer.
Vivos Notable Stakeholders
A Vivos stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vivos often face trade-offs trying to please all of them. Vivos' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vivos' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Korenko | President CEO, Director | Profile | |
| CPA CPA | Chief Officer | Profile | |
| FuMin Su | Chief Officer | Profile | |
| PE MS | Chief Mang | Profile | |
| Carlton DDS | Independent Sec | Profile | |
| Dr BSc | Chief Officer | Profile |
About Vivos Management Performance
The success or failure of an entity such as Vivos Inc often depends on how effective the management is. Vivos management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vivos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vivos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. VIVOS INC operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1 people.
The data published in Vivos' official financial statements typically reflect Vivos' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Vivos' quantitative information. For example, before you start analyzing numbers published by Vivos accountants, it's essential to understand Vivos' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Vivos Workforce Analysis
Traditionally, organizations such as Vivos use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vivos within its industry.Vivos Manpower Efficiency
Return on Vivos Manpower
| Revenue Per Employee | 14.9K | |
| Revenue Per Executive | 2.5K | |
| Net Loss Per Employee | 2.5M | |
| Net Loss Per Executive | 421.3K |
Other Information on Investing in Vivos OTC Stock
Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.